Instil Bio, Inc.
Clinical-stage biopharma developing TIL therapies to treat solid tumors.
TIL | US
Overview
Corporate Details
- ISIN(s):
- US45783C2008
- LEI:
- Country:
- United States of America
- Address:
- 3963 MAPLE AVENUE, 75219 DALLAS
- Website:
- https://instilbio.com/
- Sector:
- Manufacturing
Description
Instil Bio, Inc. is a clinical-stage biopharmaceutical company that develops novel cell therapies for the treatment of cancer. The company's work has centered on developing a pipeline of autologous tumor-infiltrating lymphocyte (TIL) therapies designed to target solid tumors. Its lead asset is AXN-2510, a therapeutic candidate for solid tumor cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
|
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB
Full Filing History RestrictedAccess to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset. |
|||||
Automate Your Workflow. Get a real-time feed of all Instil Bio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Instil Bio, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Instil Bio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
